![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-dalbavancin-hydrochloride-98816.pdf
https://finance.yahoo.com/news/paladin-labs-announces-launch-xydalba-123000837.html
https://www.nih.gov/news-events/news-releases/trial-existing-antibiotic-treating-staphylococcus-aureus-bacteremia-begins
https://www.biospace.com/article/releases/correvio-highlights-fda-acceptance-of-united-therapeutics-trevyent-new-drug-application/?s=95
https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-appoints-david-melnick-md-chief-medical
https://www.prnewswire.com/news-releases/cipher-pharmaceuticals-and-cardiome-pharma-announce-strategic-transaction-for-canadian-business-portfolio-of-cardiome-677363803.html
http://www.pharmatimes.com/news/smc_oks_four_new_therapies_for_nhs_use_in_scotland_1184395
http://www.pharmatimes.com/news/uk_launch_for_cardiomes_skin_infections_antibiotic_1180988
http://www.angelinipharma.com/wps/wcm/connect/com/home/press-room/press-releases/angelini+confirms+commitment+in+infection+control+and+infectious+diseases+area